SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-028807
Filing Date
2022-08-09
Accepted
2022-08-09 07:11:57
Documents
13
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10040479_8k.htm   iXBRL 8-K 28822
2 EXHIBIT 99.1 brhc10040479_ex99-1.htm EX-99.1 119237
  Complete submission text file 0001140361-22-028807.txt   301087

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20220809.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20220809_lab.xml EX-101.LAB 23290
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20220809_pre.xml EX-101.PRE 16550
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040479_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 221146360
SIC: 2836 Biological Products, (No Diagnostic Substances)